Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 21
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interleukin-16 is increased in obesity and alters adipogenesis and inflammation in vitro

  • Reyes-Farias, Marjorie|||0000-0001-9179-7251
  • Fernández-García, Pablo|||0000-0001-8018-5954
  • Corrales, Patricia|||0000-0002-9817-8389
  • González, Lorena
  • Soria-Gondek, Andrea|||0000-0002-7210-0073
  • Martínez, Ester
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Tarascó, Jordi
  • Moreno Santabarbara, Pablo|||0000-0002-6652-120X
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Medina-Gómez, Gema|||0000-0001-8169-681X
  • Sánchez-Infantes, David|||0000-0001-6086-7501
  • Herrero, Laura|||0000-0003-4244-4673
Introduction: Obesity is a chronic condition associated with low-grade inflammation mainly due to immune cell infiltration of white adipose tissue (WAT). WAT is distributed into two main depots: subcutaneous WAT (sWAT) and visceral WAT (vWAT), each with different biochemical features and metabolic roles. Proinflammatory cytokines including interleukin (IL)-16 are secreted by both adipocytes and infiltrated immune cells to upregulate inflammation. IL-16 has been widely studied in the peripheral proinflammatory immune response; however, little is known about its role in adipocytes in the context of obesity. Aim & Methods: We aimed to study the levels of IL-16 in WAT derived from sWAT and vWAT depots of humans with obesity and the role of this cytokine in palmitate-exposed 3T3-L1 adipocytes. Results: The results demonstrated that IL-16 expression was higher in vWAT compared with sWAT in individuals with obesity. In addition, IL-16 serum levels were higher in patients with obesity compared with normal-weight individuals, increased at 6 months after bariatric surgery, and at 12 months after surgery decreased to levels similar to before the intervention. Our in vitro models showed that IL-16 could modulate markers of adipogenesis (Pref1), lipid metabolism (Plin1, Cd36, and Glut4), fibrosis (Hif1a, Col4a, Col6a, and Vegf), and inflammatory signaling (IL6) during adipogenesis and in mature adipocytes. In addition, lipid accumulation and glycerol release assays suggested lipolysis alteration. Discussion: Our results suggest a potential role of IL-16 in adipogenesis, lipid and glucose homeostasis, fibrosis, and inflammation in an obesity context.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of Genetic Loci Associated With Intracerebral Hemorrhage Using a Multitrait Analysis Approach

  • Muiño, Elena|||0000-0001-5839-7328
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Cullell, Natalia|||0000-0001-5118-1014
  • Lledós, Miquel|||0000-0001-8832-789X
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Villatoro-González, Paula|||0009-0001-0287-4073
  • Sierra-Marcos, Alba|||0000-0001-6570-9318
  • Ros-Castelló, Victoria|||0000-0002-9523-3012
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Background and Objectives Genome-wide association studies (GWASs) have only 2 loci associated with spontaneous intracerebral hemorrhage (ICH): APOE for lobar and 1q22 for nonlobar ICH. We aimed to discover new loci through an analysis that combines correlated traits (multi-trait analysis of GWAS [MTAG]) and explore a gene-based analysis, transcriptome-wide association study (TWAS), and proteome-wide association study (PWAS) to understand the biological mechanisms of spontaneous ICH providing potential therapeutic targets. Methods We use the published MTAG of ICH (patients with spontaneous intraparenchymal bleeding) and small-vessel ischemic stroke. For all ICH, lobar ICH, and nonlobar ICH, a pairwise MTAG combined ICH with traits related to cardiovascular risk factors, cerebrovascular diseases, or Alzheimer disease (AD). For the analysis, we assembled those traits with a genetic correlation ≥0.3. A new MTAG combining multiple traits was performed with those traits whose pairwise MTAG yielded new GWAS-significant single nucleotide polymorphisms (SNPs), with a posterior-probability of model 3 (GWAS-pairwise) ≥0.6. We perform TWAS and PWAS that correlate the genetic component of expression or protein levels with the genetic component of a trait. We use the ICH cohort from UK Biobank as replication. Results For all ICH (1,543 ICH, 1,711 controls), the mean age was 72 ± 2 in cases and 70 ± 2 in controls, and half of them were women. Replication cohort: 700 ICH and 399,717 controls. Novel loci were found only for all ICH (the trait containing lobar and nonlobar ICH), combining data of ICH and small vessel stroke, white matter hyperintensities volume, fractional anisotropy, mean diffusivity, and AD. We replicated 6 SNPs belonging to 2q33.2 (ICA1L, β = 0.20, SE = 0.03, p value = 8.91 × 10), 10q24.33 (OBFC1, β = -0.12, SE = 0.02, p value = 1.67 × 10), 13q34 (COL4A2, β = 0.02, SE = 0.02, p value = 2.34 × 10), and 19q13.32 (APOC1, β = -0.19, SE = 0.03, p value = 1.38 × 10; APOE, β = 0.21, SE = 0.03, p value = 2.70 × 10; PVRL2:CTB-129P6.4, β = 0.15, SE = 0.03, p value = 1.38 × 10); 2 genes (SH3PXD2A, Z-score = 4.83, p value = 6.67 × 10; and APOC1, Z-score: = 5.11, p value = 1.60 × 10); and ICA1L transcript (Z-score = 6.8, p value = 9.1 × 10) and protein levels (Z-score = -5.8, p value = 6.7 × 10).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Influence of the Gut Microbiota on Acute Ischemic Stroke Functional Outcomes at Three Months

  • Lledós, Miquel|||0000-0001-8832-789X
  • Prats Sánchez, Luis Antonio|||0000-0002-3192-4631
  • Muiño, Elena|||0000-0001-5839-7328
  • Cullell, Natalia|||0000-0001-5118-1014
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Marín-Bueno, Rebeca|||0000-0002-0354-6602
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Guasch Jiménez, Marina|||0000-0001-6024-8348
  • Ezcurra Diaz, Garbiñe|||0000-0002-9511-3117
  • Camps-Renom, Pol|||0000-0001-6587-6271
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Freijo, María del Mar
Background: Functional recovery from ischemic stroke (IS), the main cause of adult disability worldwide, is influenced by many factors, and a portion of interindividual variability remains unexplained. Methods: Observational study in a tertiary stroke centre of patients with IS analyzed using shotgun metagenomic sequencing (January 2020-March 2022). Functional outcomes were assessed according to modified Rankin Scale (mRS) scores 3-months post-IS, considering 0-2 favorable and 3-6 unfavorable. The causal relationship between several bacteria and post-IS outcomes was explored via two-sample Mendelian randomization (MR) analyses using Genome-Wide Association Analysis (GWAS) summary statistics. Results: Comparing 128 patients with favorable and unfavorable post-IS functional outcomes, β-diversity analysis showed a separation in microbial structure, and α-diversity measures revealed greater bacterial richness in the favorable outcomes group. Taxonomic profiling of the samples showed that a greater abundance of pathogenic bacteria (e.g., Pseudomonas, Finegoldia, Porphyromonas) was associated with an unfavorable outcome. Functional profiling of the samples revealed differences in the ethylbenzene degradation pathway and in 16S rRNA (uracil1498-N3)-methyltransferase. MR confirmed increased pyruvate levels to be causally associated with post-IS favorable outcomes (β = -0.50, 95% CI: -0.91, -0.10). Conclusions: Our study points to gut microbiota differences in patients with unfavorable versus favorable 3-month post-IS outcomes. Patients with unfavorable outcomes presented gut microbiota dysbiosis and alterations in multiple metabolic pathways. Trial Registration: This study was registered on 3 October 2021 with https://clinicaltrials.gov. Access number: NCT04795687.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Lipodystrophy in HIV, Evolving Challenges and Unresolved Questions

  • Girlat, Marta|||0000-0001-7968-4190
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Quesada-López, Tania|||0000-0002-7818-4351
  • Cereijo, Rubén|||0000-0002-1108-230X
  • Villarroya, Francesc|||0000-0003-1266-9142
The advent of effective antiretroviral therapy in the mid-1990s, which successfully prevented the progression to AIDS in people living with HIV (PLWH), was associated with the appearance of the so-called HIV-associated lipodystrophy. This condition involved subcutaneous fat atrophy; abdominal fat hypertrophy; and, in some cases, lipomatosis. It was also associated with systemic metabolic disturbances, primarily insulin resistance and dyslipidemia. Following the replacement of certain antiretroviral drugs, particularly the thymidine-analog reverse transcriptase inhibitors stavudine and zidovudine, with less toxic alternatives, the incidences of lipoatrophy and lipomatosis significantly declined. However, lipodystrophy resulting from first-generation antiretroviral therapy does not always resolve after switching to newer agents. Although the widespread use of modern antiretroviral drugs-especially integrase strand transfer inhibitors and non-lipoatrophic reverse transcriptase inhibitors such as tenofovir alafenamide-has reduced the incidences of severe forms of lipodystrophy, these regimens are not entirely free of adipose tissue-related effects. Notably, they are associated with weight gain that resembles common obesity and can have adverse cardiometabolic consequences. Recent evidence also suggests the hypertrophy of specific fat depots, such as epicardial and perivascular adipose tissue, in PLWH on last-generation treatments, potentially contributing to increased cardiovascular risk. This evolving landscape underscores the persistent vulnerability of PLWH to adipose tissue alterations. While these morphological changes may not be as pronounced as those seen in classic HIV-associated lipodystrophy, they can still pose significant health risks. The continued optimization of treatment regimens and the vigilant monitoring of adipose tissue alterations and metabolic status remain essential strategies to improve the health of PLWH.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Reduced circulating levels of CXCL14 are associated with cardiovascular damage in people living with HIV

  • Quesada-López, Tania|||0000-0002-7818-4351
  • Mestres-Arenas, Alberto
  • Prieto, Paula Florencia|||0000-0003-1978-758X
  • Mur, Isabel|||0000-0001-7660-8483
  • Hidalgo Pérez, José Alberto
  • Villarroya, Joan|||0000-0002-7859-1109
  • Gutierrez, Mª del Mar|||0000-0002-0691-1206
  • Mateo, María Gracia|||0000-0003-1389-9310
  • Domingo, Joan Carles|||0000-0002-6356-0836
  • Villarroya, Francesc|||0000-0003-1266-9142
  • Girlat, Marta|||0000-0001-7968-4190
  • Cereijo, Rubén|||0000-0002-1108-230X
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Guimarães, Mariana P.
  • Planavila, Anna
Combined antiretroviral therapy (cART) has improved quality of life of people living with HIV (PLWH). However, alterations in adiposity with concomitant cardiovascular disease (CVD) and circulating systemic disturbances reminiscent of the metabolic syndrome still occur. We recently identified chemokine C-X-C motif ligand 14 (CXCL14) as a brown adipokine involved in M2 macrophage migration to adipose tissues to promote energy expenditure and insulin sensitivity, also exerting cardioprotective actions. Here, we aimed to study CXCL14 regulation and potential association with CVD in PLWH. Serum levels of CXCL14 and adipocytokines of interest were quantified in cohort of 50 cART-treated PLWH and 38 age- and sex-matched controls (50.6 ± 10.1 years, 74.1 % males). Adipose biopsies were extracted for CXCL14 mRNA expression assessment using RT-qPCR. Cardiac computed tomography angiography with contrast-enhanced scan was used to determine atherosclerotic coronary burden, and multivariant models were used to integrate data. CXCL14 circulating levels and mRNA expression in subcutaneous fat were reduced in cART-treated PLWH, especially women. While no association with insulin resistance was observed, circulating CXCL14 negatively correlated with visceral adiposity and tumor necrosis factor alpha (TNFα), fibroblast growth factor 23 (FGF23) and phospholipase A2 Group VII (PLA2G7) levels, and with presence of noncalcified atheromatous plaque in PLWH. This reduction in CXCL14 levels and negative association with inflammation and visceral fat in cART-treated PLWH were reminiscent of its regulation in diabesity. Despite further research is needed, association of circulating CXCL14 with noncalcified atheromatous plaque can result in applications as a novel subclinical biomarker for CVD in PLWH.
Repisalud
Publicación Artículo científico (JournalArticle)

Microbiota translocation following intestinal barrier disruption promotes Mincle-mediated training of myeloid progenitors in the bone marrow.

  • Robles-Vera, Iñaki
  • Jarit-Cabanillas, Aitor
  • Brandi, Paola
  • Martínez-López, María
  • Martínez-Cano, Sarai
  • Rodrigo-Tapias, Manuel
  • Femenía-Muiña, Marcos
  • Redondo-Urzainqui, Ana
  • Nuñez, Vanesa
  • González-Correa, Cristina
  • Moleón, Javier
  • Duarte, Juan
  • Conejero, Laura
  • Mata-Martínez, Pablo
  • Díez-Rivero, Carmen María
  • Bergón-Gutiérrez, Marta
  • Fernández-López, Iván
  • Gómez, Manuel J
  • Quintas, Ana
  • Dopazo, Ana
  • Sánchez-Cabo, Fátima
  • Pariente, Esther
  • Del Fresno, Carlos
  • Subiza, José Luis
  • Iborra, Salvador
  • Sancho, David
Impairment of the intestinal barrier allows the systemic translocation of commensal bacteria, inducing a proinflammatory state in the host. Here, we investigated innate immune responses following increased gut permeability upon administration of dextran sulfate sodium (DSS) in mice. We found that Enterococcus faecalis translocated to the bone marrow following DSS treatment and induced trained immunity (TI) hallmarks in bone-marrow-derived mouse macrophages and human monocytes. DSS treatment or heat-killed E. faecalis reprogrammed bone marrow progenitors (BMPs), resulting in enhanced inflammatory responses in vitro and in vivo and protection against subsequent pathogen infections. The C-type lectin receptor Mincle (Clec4e) was essential for E. faecalis-induced TI in BMPs. Clec4e mice showed impaired TI upon E. faecalis administration and reduced pathology following DSS treatment. Thus, Mincle sensing of E. faecalis induces TI that may have long-term effects on pathologies associated with increased gut permeability.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A network-based model to assess vaccination strategies for the COVID-19 pandemic by using Bayesian optimization

  • González Parra, Gilberto Carlos
  • Villanueva-Oller, Javier
  • Navarro-González, F. J.
  • Ceberio, Josu
  • Luebben, Giulia
[EN] In this paper we build a network-based model to evaluate and compare vaccination plans in order to find the optimal strategies. The age-structured model is designed to take into account the comorbidity status and vaccination hesitancy of the population. The network-based model is calibrated to reported infected cases and deaths in the USA in order to obtain an approximated realistic scenario to test the vaccination strategies. We adapt an algorithm that is based on Bayesian optimization over permutation spaces with heuristics in order to deal with the discrete space of the vaccination strategies. We also developed an ad -hoc randomized algorithm which has a higher computational cost. Both algorithms provide similar patterns of the best found vaccination strategies. We find that these best vaccination plans prioritize the age-groups 40-59 and 60-69 years old, both with comorbidities. This result shows the highly nonlinear complexity related to the problem and its dependence on social contacts and case fatality rates. The developed network-based model adapts well to the uncertainty and heterogeneity of the real world situation and allows us to assess the efficacy of many vaccination strategies. The stochastic nature of the simulations enables us to explore additional potential scenarios and the findings offer useful information for developing vaccination plans for other future potential pandemics., The first author acknowledges funding from Maria Zambrano (UPV, Ministry of Universities of Spain, and the European Union's Next-Generation EU) and aid to promote postdoctoral research from the UPV (PAID-PD-22) . This research is supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103451. Josu Ceberio has been partially supported by the Basque Government, Spain (through project KK-2022/00106, KK-2023/00012, and Consolidated Groups grant IT1504-22) . The authors are grateful to the reviewers for their careful reading of this manuscript and their useful comments to improve the content of this paper.
eBiltegia. Repositorio Institucional de Mondragon Unibertsitatea
Publicación Contribución de congreso (ConferenceOutput)

Towards a probabilistic error correction approach for improved drone battery health assessment

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung

  • Moreo, Eduardo
  • Jarit-Cabanillas, Aitor
  • Robles-Vera, Iñaki
  • Uranga, Santiago
  • Guerrero, Claudia
  • Gómez, Ana Belén
  • Mata-Martínez, Pablo
  • Minute, Luna
  • Araujo-Voces, Miguel
  • Felgueres, María José
  • Esteso, Gloria
  • Uranga-Murillo, Iratxe
  • Arias, Maykel
  • Pardo, Julián
  • Martín, Carlos
  • Valés-Gómez, Mar
  • del Fresno, Carlos
  • Sancho, David
  • Aguiló, Nacho
Intravesical administration of Bacillus Calmette-Guérin (BCG) was one of the first FDA-approved immunotherapies and remains a standard treatment for bladder cancer. Previous studies have demonstrated that intravenous (IV) administration of BCG is well-tolerated and effective in preventing tuberculosis infection in animals. Here, we examine IV BCG in several preclinical lung tumor models. Our findings demonstrate that BCG inoculation reduced tumor growth and prolonged mouse survival in models of lung melanoma metastasis and orthotopic lung adenocarcinoma. Moreover, IV BCG treatment was well-tolerated with no apparent signs of acute toxicity. Mechanistically, IV BCG induced tumor-specific CD8+ T cell responses, which were dependent on type 1 conventional dendritic cells, as well as NK cell-mediated immunity. Lastly, we also show that IV BCG has an additive effect on anti-PD-L1 checkpoint inhibitor treatment in mouse lung tumors that are otherwise resistant to anti-PD-L1 as monotherapy. Overall, our study demonstrates the potential of systemic IV BCG administration in the treatment of lung tumors, highlighting its ability to enhance immune responses and augment immune checkpoint blockade efficacy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Generation of the antioxidant hydroxytyrosol from tyrosol present in beer and red wine in a randomized clinical trial

  • Soldevila-Domenech, Natalia
  • Boronat, Anna|||0000-0003-0852-3634
  • Mateus Rodriguez, Julian Andres|||0000-0001-8417-3539
  • Díaz-Pellicer, Patricia
  • Matilla, Iris
  • Pérez-Otero, Marta
  • Aldea-Perona, Ana|||0000-0002-3791-8814
  • Torre, Rafael de la|||0000-0002-6765-1866
Beer and wine contains the simple phenol tyrosol (TYR) which is endogenously converted into hydroxytyrosol (HT), one of the strongest dietary antioxidants, by CYP2A6 and CYP2D6 polymorphic enzymes. We investigated in humans the rate of this bioconversion after beer and red wine (RW) intake. In a single blind, randomized, crossover, controlled clinical trial (n = 20 healthy subjects), we evaluated TYR absorption and biotransformation into HT following a single dose of (i) RW, (ii) Indian pale ale beer (IPA), (iii) blonde beer, and (iv) non-alcoholic beer (free). Individuals were genotyped for CYP2A6 and CYP2D6, and a polygenic activity score (PAS) was derived. RW triggered the highest increase in total TYR recovered, followed by IPA, blonde, and free beers. Although the HT content in beer was minimal, an increase in HT production was observed in all beers following TYR in a dose-response manner, confirming TYR to HT biotransformation. Sex differences were identified in the rate of the conversion following RW. PAS scores correlated linearly with the recoveries of HT (HT:TYR ratios) after RW intake. In conclusion, after beer and RWconsumption, TYR is absorbed and endogenously biotransformed into HT. This mechanism could be modulated by sex, genetics, and matrix components.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Data on the endogenous conversion of tyrosol into hydroxytyrosol in humans

  • Boronat, Anna|||0000-0003-0852-3634
  • Mateus Rodriguez, Julian Andres|||0000-0001-8417-3539
  • Soldevila-Domenech, Natalia
  • Guerra, Mercè
  • Rodríguez-Morató, Jose|||0000-0002-8133-9983
  • Varon, Carlota
  • Muñoz Aguayo, Daniel|||0000-0001-8173-0168
  • Barbosa, Francina
  • Morales, Juan Carlos|||0000-0003-2400-405X
  • Gaedigk, Andreas
  • Langohr, Klaus|||0000-0001-7075-9192
  • Covas Planells, Maria Isabel
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Tyndale, Rachel F.
  • Torre, Rafael de la|||0000-0002-6765-1866
Here we present new and original data on the endogenous conversion of tyrosol (Tyr) into hydroxytyrosol (OHTyr) in humans and its effects on the cardiovascular system. A randomized, crossover, controlled clinical trial was performed with individuals at cardiovascular risk (n = 33). They received white wine (WW) (females 1, males 2 standard drinks/day), WW plus Tyr capsules (WW + Tyr) (25mg Tyr capsule, one per WW drink), and water (control) ad libitum. Intervention periods were of 4 weeks preceded by three-week wash-out periods. We assessed the conversion of Tyr to OHTyr, its interaction with a polygenic activity score (PAS) from CYP2A6 and CYP2D6 genotypes, and the effects on cardiovascular risk markers. For further details and experimental findings please refer to the article "Cardiovascular benefits of tyrosol and its endogenous conversion into hydroxytyrosol in humans. A randomized, controlled trial" [].
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID, E-SPERANZA COVID Project study protocol

  • Mera Cordero, Francisco|||0000-0002-6599-0506
  • Bonet Monné, Sara|||0000-0002-0813-9221
  • Almeda, J.|||0000-0002-7602-0679
  • García Sangenís, Ana|||0000-0002-6689-6466
  • Cunillera, O.|||0000-0003-2891-099X
  • Contreras-Martos, Sara
  • Álvarez Muñoz, Gemma
  • Monfà Escolà, Ramon
  • Balanzó Joué, Marina
  • Morros, Rosa|||0000-0001-6752-8748
  • Salvador-Gonzalez, Betlem
The coronavirus disease 2019 (COVID-19) pandemic continues to affect the globe. After 18 months of the SARS-CoV-2 emergence, clinicians have clearly defined a subgroup of patients with lasting, disabling symptoms. While big strides have been made in understanding the acute phase of SARS-CoV-2 infection, the pathophysiology of long COVID is still largely unknown, and evidence-based, effective treatments for this condition remain unavailable. To evaluate the efficacy of 10 mg oral montelukast every 24 h versus placebo in improving quality of life associated with mild to moderate respiratory symptoms in patients with long COVID as measured with the COPD Assessment Test (CAT) questionnaire. The secondary objectives will evaluate the effect of montelukast versus placebo on improving exercise capacity, COVID-19 symptoms (asthenia, headache, mental confusion or brain fog, ageusia, and anosmia), oxygen desaturation during exertion, functional status, and mortality. Phase III, randomized, double-blind clinical trial. We will include 18- to 80-year-old patients with SARS-CoV-2 infection and mild to moderate respiratory symptoms lasting more than 4 weeks. Participants will be randomly allocated in a 1:1 ratio to the intervention (experimental treatment with 10 mg/day montelukast) or the control group (placebo group), during a 28-day treatment. Follow-up will finish 56 days after the start of treatment. The primary outcome will be health-related quality of life associated with respiratory symptoms according to the COPD Assessment Test 4 weeks after starting the treatment. The following are the secondary outcomes: (a) exercise capacity and oxygen saturation (1-min sit-to-stand test); (b) Post-COVID-19 Functional Status Scale; (c) other symptoms: asthenia, headache, mental confusion (brain fog), ageusia, and anosmia (Likert scale); (d) use of healthcare resources; (e) mortality; (f) sick leave duration in days; and (g) side effects of montelukast. This study has been approved by the Clinical Research Ethics Committee of the IDIAPJGol (reference number 21/091-C). The trial results will be published in open access, peer-reviewed journals and explained in webinars to increase awareness and understanding about long COVID among primary health professionals. Registered on January 5, 2021. EudraCT number 2021-000605-24. Prospectively registered.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Barriers, facilitators, and proposals for improvement in the implementation of a collaborative care program for depression, a qualitative study of primary care physicians and nurses

  • Aragonès, Enric|||0000-0002-5245-4667
  • López-Cortacans, Germán|||0000-0001-6910-3284
  • Cardoner, Narcís|||0000-0001-9633-0888
  • Tomé-Pires, Catarina|||0000-0001-7347-4950
  • Porta-Casteràs, Daniel|||0000-0002-3921-3607
  • Palao, Diego|||0000-0002-3323-6568
Primary care plays a central role in the treatment of depression. Nonetheless, shortcomings in its management and suboptimal outcomes have been identified. Collaborative care models improve processes for the management of depressive disorders and associated outcomes. We developed a strategy to implement the INDI collaborative care program for the management of depression in primary health care centers across Catalonia. The aim of this qualitative study was to evaluate a trial implementation of the program to identify barriers, facilitators, and proposals for improvement. One year after the implementation of the INDI program in 18 public primary health care centers we performed a qualitative study in which the opinions and experiences of 23 primary care doctors and nurses from the participating centers were explored in focus groups. We performed thematic content analysis of the focus group transcripts. The results were organized into three categories: facilitators, barriers, and proposals for improvement as perceived by the health care professionals involved. The most important facilitator identified was the perception that the INDI collaborative care program could be a useful tool for reorganizing processes and improving the management of depression in primary care, currently viewed as deficient. The main barriers identified were of an organizational nature: heavy workloads, lack of time, high staff turnover and shortages, and competing demands. Additional obstacles were inertia and resistance to change among health care professionals. Proposals for improvement included institutional buy-in to guarantee enduring support and the organizational changes needed for successful implementation. The INDI program is perceived as a useful, viable program for improving the management of depression in primary care. Uptake by primary care centers and health care professionals, however, was poor. The identification and analysis of barriers and facilitators will help refine the strategy to achieve successful, widespread implementation. ClinicalTrials.gov identifier: ; Registered 18th September, 2017.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy

  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Girlat, Marta|||0000-0001-7968-4190
  • Gavaldà i Navarro, Aleix|||0000-0001-8421-3174
  • Blasco-Roset, Albert|||0000-0002-4686-6075
  • Delgado-Anglés, Alejandro|||0000-0002-6996-6327
  • Gallego-Escuredo, José Miguel
  • Gutierrez, Mª del Mar|||0000-0002-0691-1206
  • Mateo, María Gracia|||0000-0003-1389-9310
  • Cereijo, Rubén|||0000-0002-1108-230X
  • Domingo, Joan Carles|||0000-0002-6356-0836
  • Villarroya, Francesc|||0000-0003-1266-9142
  • Villarroya, Joan
Lipodystrophy is a major disturbance in people living with HIV-1 (PLWH). Several systemic alterations in PLWH are reminiscent of those that occur in ageing. It is unknown whether the lipodystrophy in PLWH is the consequence of accelerated ageing in adipose tissue. We compared systemic and adipose tissue disturbances in PLWH with those in healthy elderly individuals (~80 y old). We observed similarly enhanced expression of inflammation-related genes and decreased autophagy in adipose tissues from elderly individuals and PLWH. Indications of repressed adipogenesis and mitochondrial dysfunction were found specifically in PLWH, whereas reduced telomere length and signs of senesce were specific to elderly individuals. We conclude that ageing of adipose tissue accounts only partially for the alterations in adipose tissues of PLWH.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes

  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Quesada-López, Tania|||0000-0002-7818-4351
  • Villarroya, Joan
  • Cairó, Montserrat
  • Gutierrez, Mª del Mar|||0000-0002-0691-1206
  • Mateo, Maria Gracia
  • Mur, Isabel|||0000-0001-7660-8483
  • Corbacho, Noemí
  • Domingo, Joan Carles|||0000-0002-6356-0836
  • Villarroya, Francesc|||0000-0003-1266-9142
  • Girlat, Marta|||0000-0001-7968-4190
Aims: To assess the potential direct effects of the integrase strand-transfer inhibitors (INsTIs) dolutegravir, bictegravir, and raltegravir, drugs used as treatment for people living with human immunodeficiency virus (PLWH), on human adipose cells. Main methods: Drugs were added to the differentiation medium of human Simpson-Golabi-Behmel syndrome (SGBS) adipose cells and morphological adipogenesis was monitored for 10 days. Also, adipocytes were exposed to drugs following differentiation (day 14). The gene expression levels of selected adipogenesis markers, adipocyte metabolism markers, adipokines, and cytokines were determined by quantitative-reverse transcription polymerase-chain reaction. The release of adiponectin and leptin into the culture medium was measured using specific enzyme-linked immunosorbent assay, and release of interleukin-6 and chemokine (C[sbnd]C motif) ligand-2 using Multiplex assays. Key findings: Overall morphological adipogenesis was unaltered by INsTIs. The expression of adipogenesis marker genes (peroxisome proliferator-activated receptor-Ɣ and lipoprotein lipase) was slightly reduced in dolutegravir-treated differentiating adipocytes. Bictegravir repressed gene expression and the release of pro-inflammatory cytokines in differentiating adipocytes. Dolutegravir and raltegravir increased interleukin-6 gene expression, but only dolutegravir increased interleukin-6 release. Dolutegravir repressed adiponectin expression and release in differentiating adipocytes and had a similar but milder effect on leptin. Drug treatment of mature adipocytes reduced adiponectin gene expression in response to dolutegravir. Significance: The INsTIs studied do not have a significant effect on human adipose cell differentiation but exert distinct effects on gene expression and secretion of adipokines and cytokines. These findings will help understand and manage the effects of INsTI-containing treatments on body weight and metabolic dysregulation in PLWH.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD

  • Weber, Minéia
  • Mera, Paula|||0000-0001-8941-4637
  • Casas, Josefina|||0000-0002-7926-5209
  • Salvador, Javier
  • Rodríguez, Amaia|||0000-0002-2180-461X
  • Alonso Muñoz, Sergio|||0000-0002-3989-8757
  • Sebastián, David|||0000-0002-7260-3869
  • Soler Vázquez, M. Carmen|||0000-0003-1430-5617
  • Montironi, Carla|||0000-0002-1453-2193
  • Recalde, Sandra|||0000-0002-6174-0649
  • Fucho, Raquel|||0000-0002-1774-9099
  • Calderon-Dominguez, María|||0000-0003-1797-3450
  • Mir, Joan Francesc|||0000-0001-8501-0969
  • Bartrons, Ramon|||0000-0001-9349-5847
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Sánchez-Infantes, David|||0000-0001-6086-7501
  • Zorzano Olarte, Antonio|||0000-0002-1638-0306
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
  • Casals, Nuria|||0000-0002-6719-4300
  • Valentí, Victor|||0000-0002-7074-2849
  • Frühbeck, Gema|||0000-0002-8305-7154
  • Herrero, Laura|||0000-0003-4244-4673
  • Serra, Dolors|||0000-0002-4936-4206
The prevalence of nonalcoholic fatty liver disease (NAFLD) has increased drastically due to the global obesity pandemic but at present there are no approved therapies. Here, we aimed to revert high-fat diet (HFD)-induced obesity and NAFLD in mice by enhancing liver fatty acid oxidation (FAO). Moreover, we searched for potential new lipid biomarkers for monitoring liver steatosis in humans. We used adeno-associated virus (AAV) to deliver a permanently active mutant form of human carnitine palmitoyltransferase 1A (hCPT1AM), the key enzyme in FAO, in the liver of a mouse model of HFD-induced obesity and NAFLD. Expression of hCPT1AM enhanced hepatic FAO and autophagy, reduced liver steatosis, and improved glucose homeostasis. Lipidomic analysis in mice and humans before and after therapeutic interventions, such as hepatic AAV9-hCPT1AM administration and RYGB surgery, respectively, led to the identification of specific triacylglyceride (TAG) specie (C50:1) as a potential biomarker to monitor NAFFLD disease. To sum up, here we show for the first time that liver hCPT1AM gene therapy in a mouse model of established obesity, diabetes, and NAFLD can reduce HFD-induced derangements. Moreover, our study highlights TAG (C50:1) as a potential noninvasive biomarker that might be useful to monitor NAFLD in mice and humans.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes

  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Muiño, Elena|||0000-0001-5839-7328
  • Cullell, Natalia|||0000-0001-5118-1014
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Lledós, Miquel|||0000-0001-8832-789X
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Planas, Anna Maria|||0000-0002-6147-1880
  • DeDiego, Marta L.|||0000-0002-7888-7372
  • De Felipe, Alicia
  • Masjuan, Jaime|||0000-0003-1329-0943
  • García-Madrona, Sebastián
  • Segura, Tomás|||0000-0003-3625-0987
  • González-Villar, Esther
  • Serrano-Heras, Gemma|||0000-0001-9368-4832
  • Domínguez-Mayoral, Ana
  • Menéndez-Valladares, Paloma
  • Montaner, Joan|||0000-0003-4845-2279
  • Migeotte, Isabelle
  • Rahmouni, Souad
  • Darcis, Gilles|||0000-0001-8192-1351
  • Bernardo, D.|||0000-0002-2843-6696
  • Rojo, Silvia
  • Schulte, Eva C.|||0000-0003-3105-5672
  • Protzer, Ulrike|||0000-0002-9421-1911
  • Fricke, Lisa|||0000-0002-9268-0546
  • Winter, Christof|||0000-0002-0253-9056
  • Niemi, Mari E. K.
  • Cordioli, Mattia|||0000-0002-4872-0520
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
We aimed to analyse whether patients with ischaemic stroke (IS) occurring within eight days after the onset of COVID-19 (IS-COV) are associated with a specific aetiology of IS. We used SUPERGNOVA to identify genome regions that correlate between the IS-COV cohort (73 IS-COV cases vs. 701 population controls) and different aetiological subtypes. Polygenic risk scores (PRSs) for each subtype were generated and tested in the IS-COV cohort using PRSice-2 and PLINK to find genetic associations. Both analyses used the IS-COV cohort and GWAS from MEGASTROKE (67,162 stroke patients vs. 454,450 population controls), GIGASTROKE (110,182 vs. 1,503,898), and the NINDS Stroke Genetics Network (16,851 vs. 32,473). Three genomic regions were associated (p -value < 0.05) with large artery atherosclerosis (LAA) and cardioembolic stroke (CES). We found four loci targeting the genes PITX2 (rs10033464, IS-COV beta = 0.04, p -value = 2.3 × 10 -2, se = 0.02), previously associated with CES, HS6ST1 (rs4662630, IS-COV beta = -0.04, p -value = 1.3 × 10 -3, se = 0.01), TMEM132E (rs12941838 IS-COV beta = 0.05, p -value = 3.6 × 10 -4, se = 0.01), and RFFL (rs797989 IS-COV beta = 0.03, p -value = 1.0 × 10 -2, se = 0.01). A statistically significant PRS was observed for LAA. Our results suggest that IS-COV cases are genetically similar to LAA and CES subtypes. Larger cohorts are needed to assess if the genetic factors in IS-COV cases are shared with the general population or specific to viral infection.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Bridging the gap between landscape theory and planning, The GTP model in a Pyrenees mountain area

  • Serra Díaz, Josep M.|||0000-0003-1988-1154
  • Vera, Ana|||0000-0001-7865-1610
  • Pèlachs, Albert|||0000-0002-8075-1044
  • Mendizábal Riera, Enric|||0000-0002-6066-7515
The concept of landscape in Europe has moved from a scale analysis towards a holistic concept defined by laws and a European directive. In economically depressed mountain areas, the landscape represents both a resource and an opportunity for development, and the task facing managers of natural parks is not easy. The present study applied a geographic model that interprets landscape holistically using three subsystems (G-T-P): Geosystem or natural environment (G), Territory or socioeconomic environment (T) and Landscape or symbolic perceptions and values (P). We apply this methodology to possible rural development in a Pyrenean valley within a Natural Park. We showed that livestock and crop production activities have a significant role in the forest environment of the valley with no significant landscape impact. Overall, we show that GTP model enables to work within the legal definition of landscape and also identify landscape-friendly development strategies. Further research should focus on the interaction between these subsystems from the managers' perspectives.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Divergent effects of the antiretroviral drugs, dolutegravir, tenofovir alafenamide, and tenofovir disoproxil fumarate, on human adipocyte function

  • Quesada-López, Tania|||0000-0002-7818-4351
  • Blasco-Roset, Albert|||0000-0002-4686-6075
  • Mestres-Arenas, Alberto
  • Prieto, P.
  • Villarroya, Francesc|||0000-0003-1266-9142
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Girlat, Marta|||0000-0001-7968-4190
  • Cereijo, R.
  • Domingo, J.C.
Combined antiretroviral therapy (cART) has been associated with increased body weight accompanied by metabolic alterations in people living with human immunodeficiency virus (PLWH). To gain insight into the combined effects of cART components on adipocyte dysfunction, we assessed whether and how treatment of human adipocytes with dolutegravir (DTG) and the nucleotide-analog reverse-transcriptase inhibitors (NRTIs), tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF), alone and in combination, altered biological processes related to adipose tissue dysfunction. DTG, TAF, and TDF were applied to human Simpson-Golabi-Behmel syndrome (SGBS) adipose cells during differentiation (day 10) and ensuing differentiation (day 14). Expression of selected marker genes was determined by qPCR, the release of adipokines and inflammatory cytokines to the culture media was assessed, and cell respiration was measured. Adipogenesis was not altered by the combined treatment of human adipocytes. However, DTG at the highest dose repressed adipogenesis marker genes expression, and TAF and TDF appeared to mitigate this effect. DTG repressed the expression of adiponectin and the release of adiponectin and leptin in differentiating adipocytes, and these effects were mantained in combination with TAF and TDF. DTG plus TAF or TDF on human adipocytes enhanced inflammation and stress and increased the release of proinflammatory cytokines to the culture media. Together, our results show that combined therapy with these drugs can alter inflammation, cellular stress, and fibrosis in human adipocytes. These findings may improve our understanding and management of the effects of cART on body adiposity and metabolic dysregulation in PLWH.
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Development and characterization of graphene derivative&-GelMA hybrid bioinks for the generation of bioartificial tissue substitutes via 3D bioprinting

  • Lavín López, María del Prado
  • García García, Óscar Dario
  • Condi de Godoi, Fernanda
  • Griera Merino, Mercedes|||0000-0002-9887-6638
  • Jorba Masdéu, Ignasi
  • Campos Sánchez, Fernando
  • Frutos García, Sergio De|||0000-0002-1225-5911
  • López González, Iván
  • Baena Cañada, José Manuel
  • Carriel Araya, Víctor
  • Campillo Agulló, Noelia
26 p., The fabrication of bioartificial tissue substitutes is a complex process that relies on the application of innovative biomaterials and manufacturing techniques enabling the generation of cell-laden scaffolds mimicking natural tissue interfaces. Among the many biomaterials, gelatin methacryloyl (GelMA) hydrogels have shown great potential for three-dimensional (3D) bioprinting-based tissue engineering due to their high biocompatibility, biodegradability, and tunable mechanical properties. In this study, the potential use of hybrid hydrogels based on GelMA and a highly purified graphene-derivative (BioGraph) as biomaterials bioinks for extrusion-based 3D bioprinting was investigated. Formulations containing BioGraph concentrations of up to 0.1% w/v were well-suited for this technique, showing good extrudability with reduced clogging at the printing temperatures, effective photocrosslinking at the irradiances tested, high shape fidelity, and high resolution of the printed scaffold. In situ photocrosslinking tests revealed that BioGraph concentration decreased the speed of the photocrosslinking and the stiffness of the cured matrix. In vitro studies indicated that BioGraph content ?0.1% w/v did not have an adverse impact on the viability and proliferation of rat adipose-derived mesenchymal stem cells (r-AMSCs). Similarly, acellular scaffolds implanted subcutaneously in rats showed a local macrophage-mediated inflammatory reaction and a collagen encapsulation process without any affection of surrounded host tissues. The addition of lower concentrations of BioGraph (0.025% w/v) to the matrix resulted in enhanced macrophagic interactions and scaffold degradation in vivo, and r-AMSCs growth and proliferation in vitro. In conclusion, the GelMA?BioGraph hybrid hydrogels developed here demonstrate enhanced rheological and biological properties, tailored for extrusion-based 3D bioprinting with applications in the engineering of soft (neural, liver, etc.) or hard (bone) tissues., Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III, Universidad de Alcalá, Ministerio de Economía y Competitividad, Agencia Estatal de Investigación, Generalitat de Catalunya